BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26224408)

  • 1. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
    Bartels M; van der Zalm MM; van Oirschot BA; Lee FS; Giles RH; Kruip MJ; Gitz-Francois JJ; Van Solinge WW; Bierings M; van Wijk R
    Hum Mutat; 2015 Nov; 36(11):1039-42. PubMed ID: 26224408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
    Pastore Y; Jedlickova K; Guan Y; Liu E; Fahner J; Hasle H; Prchal JF; Prchal JT
    Am J Hum Genet; 2003 Aug; 73(2):412-9. PubMed ID: 12844285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homozygous VHL(D126N) missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.
    Sarangi S; Lanikova L; Kapralova K; Acharya S; Swierczek S; Lipton JM; Wolfe L; Prchal JT
    Pediatr Blood Cancer; 2014 Nov; 61(11):2104-6. PubMed ID: 24729484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new
    Lenglet M; Robriquet F; Schwarz K; Camps C; Couturier A; Hoogewijs D; Buffet A; Knight SJL; Gad S; Couvé S; Chesnel F; Pacault M; Lindenbaum P; Job S; Dumont S; Besnard T; Cornec M; Dreau H; Pentony M; Kvikstad E; Deveaux S; Burnichon N; Ferlicot S; Vilaine M; Mazzella JM; Airaud F; Garrec C; Heidet L; Irtan S; Mantadakis E; Bouchireb K; Debatin KM; Redon R; Bezieau S; Bressac-de Paillerets B; Teh BT; Girodon F; Randi ML; Putti MC; Bours V; Van Wijk R; Göthert JR; Kattamis A; Janin N; Bento C; Taylor JC; Arlot-Bonnemains Y; Richard S; Gimenez-Roqueplo AP; Cario H; Gardie B
    Blood; 2018 Aug; 132(5):469-483. PubMed ID: 29891534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics.
    Remenyi G; Bereczky Z; Gindele R; Ujfalusi A; Illes A; Udvardy M
    Pathol Oncol Res; 2021; 27():1609987. PubMed ID: 34899081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene and VHL-haplotype analysis in patients with presumable congenital erythrocytosis.
    Cario H; Schwarz K; Jorch N; Kyank U; Petrides PE; Schneider DT; Uhle R; Debatin KM; Kohne E
    Haematologica; 2005 Jan; 90(1):19-24. PubMed ID: 15642664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the VHL gene in sporadic apparently congenital polycythemia.
    Pastore YD; Jelinek J; Ang S; Guan Y; Liu E; Jedlickova K; Krishnamurti L; Prchal JT
    Blood; 2003 Feb; 101(4):1591-5. PubMed ID: 12393546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
    Hudler P; Urbancic M
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.
    Hickey MM; Lam JC; Bezman NA; Rathmell WK; Simon MC
    J Clin Invest; 2007 Dec; 117(12):3879-89. PubMed ID: 17992257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of VHL gene mutations in young individuals with polycythemia and high serum erythropoietin.
    Randi ML; Murgia A; Putti MC; Martella M; Casarin A; Opocher G; Fabris F
    Haematologica; 2005 May; 90(5):689-91. PubMed ID: 15921386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital polycythemias/erythrocytoses.
    Gordeuk VR; Stockton DW; Prchal JT
    Haematologica; 2005 Jan; 90(1):109-16. PubMed ID: 15642677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis.
    Negro A; Graiani G; Nicoli D; Farnetti E; Casali B; Verzicco I; Tedeschi S; Ghirarduzzi A; Cannone V; Marco LDE; Filice A; Gemelli G; Giunta A; Cabassi A
    J Hypertens; 2020 Feb; 38(2):340-346. PubMed ID: 31568062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient.
    Núñez-Martínez PM; Taja-Chayeb L; Ramírez-Otero MA; Fragoso-Ontiveros V; Wegman-Ostrosky T; Cruz-Robles D; Vidal Millán S
    Bol Med Hosp Infant Mex; 2021 May; 78(4):341-345. PubMed ID: 33938902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF pathway and erythrocytosis.
    Lee FS; Percy MJ
    Annu Rev Pathol; 2011; 6():165-92. PubMed ID: 20939709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients.
    Chandrasekhar C; Pasupuleti SK; Sarma PVGK
    Blood Cells Mol Dis; 2020 Nov; 85():102479. PubMed ID: 32739800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
    Lappin TR; Lee FS
    Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
    Percy MJ; Furlow PW; Beer PA; Lappin TR; McMullin MF; Lee FS
    Blood; 2007 Sep; 110(6):2193-6. PubMed ID: 17579185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of unexplained erythrocytosis in Indian patients.
    Mallik N; Sharma P; Kaur Hira J; Chhabra S; Sreedharanunni S; Kumar N; Naseem S; Sachdeva MUS; Ahluwalia J; Malhotra P; Varma N; Varma S; Das R
    Eur J Haematol; 2019 Aug; 103(2):124-130. PubMed ID: 31132167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VHL gene methylation contributes to excessive erythrocytosis in chronic mountain sickness rat model by upregulating the HIF-2α/EPO pathway.
    Yang M; Zhu M; Song K; Wuren T; Yan J; Ge RL; Ji L; Cui S
    Life Sci; 2021 Feb; 266():118873. PubMed ID: 33309718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
    van Rooijen E; Voest EE; Logister I; Korving J; Schwerte T; Schulte-Merker S; Giles RH; van Eeden FJ
    Blood; 2009 Jun; 113(25):6449-60. PubMed ID: 19304954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.